Compositions and methods for virus control in Varroa mite and bees

• US 10,557,138 B2
• Filed: 12/09/2014
• Issued: 02/11/2020
• Est. Priority Date: 12/10/2013
• Status: Active Grant

• Current Assignee: GreenLight Biosciences, Inc.
• Original Assignee: Beeologics Inc.
• Inventors: Gleit-Kielmanowicz, Merav, Golani, Yael
• Primary Examiner(s): McGarry, Sean
• Application Number:
  US15/103,685
• Publication Number:
  US 20170037407A1
• Time in Patent Office: 1,890 Days
• Field of Search: None
• CPC Class Codes: C12N 15/1131 against viruses
• CPC Class Codes: C12N 2310/14 interfering N.A.
• CPC Class Codes: C12N 2320/32 Special delivery means, e.g. tissue-specific

Abstract

Compositions and methods for providing viral control in Varroa mites and bees using RNA interference technology, and more particularly, prevention and treatment of viral infections in Varroa mites and bees by providing trigger polynucleotides targeting viral sequences is disclosed.

Claims

1. A method of reducing viral load or suppressing viral replication in a Varroa destructor mite infected by a virus, the method comprising providing to the Varroa destructor mite infected by a virus a composition comprising an effective amount of at least one double-stranded RNA (dsRNA) which comprises a nucleic acid sequence that is identical or complementary to a sequence of at least 21 contiguous nucleotides of a viral gene in said virus, wherein the dsRNA downregulates expression of said viral gene in the Varroa destructor mite, thereby reducing viral load or suppressing viral replication in the Varroa destructor mite.

2. The method of claim 1, wherein said composition comprises a mixture of 2, 3, 4, 5, 6, 7, 8, 9, or 10 different dsRNAs.

3. The method of claim 1, wherein said viral gene is from a virus selected from the group consisting of Acute Bee Paralysis Virus (ABPV), Deformed Wing Virus (DWV), Kashmir Bee Virus (KBV), Black Queen Cell Virus (BQCV), Sacbrood Virus (SBV), Chronic Bee Paralysis Virus (CPV), Cloudy Wing Virus (CWV), Israeli Acute Paralysis Virus (IAPV), Invertebrate iridescent virus type 6 (IIV-6), Varroa Destructor Virus (VDV-1), and Kakugo Virus (KV).

4. The method of claim 1, wherein said at least one dsRNA comprises a nucleic acid sequence that is identical or complementary to at least 21 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NOs:

1-21.

5. A method for reducing the susceptibility of a bee to a disease caused by a virus, the method comprising providing to a Varroa destructor mite infected by said virus a composition comprising an effective amount of a double-stranded RNA (dsRNA) comprising a nucleic acid sequence that is identical or complementary to a sequence of at least 21 contiguous nucleotides of a viral gene in said virus, thereby suppressing viral replication in the Varroa destructor mite and reducing the susceptibility of the bee to the disease caused by the virus.

6. The method of claim 5, wherein said bee is a honey bee.

7. The method of claim 5, wherein the double-stranded RNA (dsRNA) comprises a nucleic acid sequence that is identical or complementary to at least 21 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NOs:

1-10 and 21.

8. The method of claim 5, wherein the virus is selected from the group consisting of Acute Bee Paralysis Virus (ABPV), Deformed Wing Virus (DWV), Kashmir Bee Virus (KBV), Black Queen Cell Virus (BQCV), Sacbrood Virus (SBV), Chronic Bee Paralysis Virus (CPV), Cloudy Wing Virus (CWV), Israeli Acute Paralysis Virus (IAPV), Invertebrate iridescent virus type 6 (IIV-6), Varroa Destructor Virus (VDV-1), and Kakugo Virus (KV).